Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials
NHS hospitals in England used £258,501,203 of indicative cost of Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials in the 12 months to July 2026, about 1.0% of all hospital medicines spend. That is up 5.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Clatterbridge Cancer Centre Nhs Ft | £17,527,982 |
| The Christie Nhs Foundation Trust | £15,274,591 |
| Sheffield Teaching Hospitals Nhs Trust | £6,474,430 |
| The Royal Marsden Nhs Foundation Trust | £6,459,962 |
| Barts Health Nhs Trust | £5,555,712 |
| East And North Hertfordshire Nhs Trust | £5,414,649 |
| Nottingham University Hospitals Trust | £5,132,523 |
| Univ Hpl B/Ham Nhs Foundation Trust | £5,132,523 |
| Southend Univ Hosp Nhs Foundation Trust | £4,995,077 |
| Royal Surrey County Hosp Nhs Found Trust | £4,940,822 |
The primary-care picture
Pertuzumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Pertuzumab medicine page.